153 related articles for article (PubMed ID: 8402466)
21. Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas.
Battista P; Muraro R; Mammarella S; Curia MC; Colasante A; Rosini S; Lesti G; Sacco R; French D; Frati L
Cancer Res; 1990 Nov; 50(21):6987-94. PubMed ID: 1698547
[TBL] [Abstract][Full Text] [Related]
22. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
[TBL] [Abstract][Full Text] [Related]
23. The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).
Szpak CA; Johnston WW; Roggli V; Kolbeck J; Lottich SC; Vollmer R; Thor A; Schlom J
Am J Pathol; 1986 Feb; 122(2):252-60. PubMed ID: 2418688
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibody B72.3 reactivity with human endometrium: a study of normal and malignant tissues.
Thor A; Viglione MJ; Muraro R; Ohuchi N; Schlom J; Gorstein F
Int J Gynecol Pathol; 1987; 6(3):235-47. PubMed ID: 3429107
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site.
Brown RW; Campagna LB; Dunn JK; Cagle PT
Am J Clin Pathol; 1997 Jan; 107(1):12-9. PubMed ID: 8980361
[TBL] [Abstract][Full Text] [Related]
26. Use of a monoclonal antibody (B72.3) as a novel immunohistochemical adjunct for the diagnosis of carcinomas in fine needle aspiration biopsy specimens.
Johnston WW; Szpak CA; Lottich SC; Thor A; Schlom J
Hum Pathol; 1986 May; 17(5):501-13. PubMed ID: 2422108
[TBL] [Abstract][Full Text] [Related]
27. Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.
Colcher D; Milenic D; Roselli M; Raubitschek A; Yarranton G; King D; Adair J; Whittle N; Bodmer M; Schlom J
Cancer Res; 1989 Apr; 49(7):1738-45. PubMed ID: 2924317
[TBL] [Abstract][Full Text] [Related]
28. Lack of specificity of monoclonal antibody B72.3 in distinguishing chronic pancreatitis from pancreatic adenocarcinoma.
Loy TS; Springer D; Chapman RK; Diaz-Arias AA; Bulatao IS; Bickel JT
Am J Clin Pathol; 1991 Dec; 96(6):684-8. PubMed ID: 1720919
[TBL] [Abstract][Full Text] [Related]
29. Immunostaining with HAM56 in the diagnosis of adenocarcinomas.
Loy TS; Abshier J
Mod Pathol; 1993 Jul; 6(4):473-5. PubMed ID: 8415595
[TBL] [Abstract][Full Text] [Related]
30. Production and characterization of a tumor-specific monoclonal antibody ACT19 recognizing an epitope distinctive from sialosyl-Tn on the TAG72 antigen.
Xiang J; Moyana T; Chen Z; Han W; Ping T; Li E
Tumori; 1993 Feb; 79(1):58-65. PubMed ID: 7684540
[TBL] [Abstract][Full Text] [Related]
31. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.
Ordóñez NG
Am J Surg Pathol; 1989 Apr; 13(4):276-91. PubMed ID: 2648877
[TBL] [Abstract][Full Text] [Related]
32. Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts.
Colcher D; Keenan AM; Larson SM; Schlom J
Cancer Res; 1984 Dec; 44(12 Pt 1):5744-51. PubMed ID: 6498836
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor.
Gomez-Fernandez C; Mejias A; Walker G; Nadji M
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):137-41. PubMed ID: 19875957
[TBL] [Abstract][Full Text] [Related]
34. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
Roselli M; Hitchcock CL; Molinolo A; Milenic DE; Colcher D; Martin EW; Hinkle GH; Schlom J
Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic heterogeneity of a tumor-associated antigen in adenocarcinomas of the colon and their metastases as demonstrated by monoclonal antibody B72.3.
Lottich SC; Szpak CA; Johnston WW; Thor A; Schlom J
Cancer Invest; 1986; 4(5):387-95. PubMed ID: 2433005
[TBL] [Abstract][Full Text] [Related]
36. Tumor associated glycoprotein-72 is highly expressed in prostatic adenocarcinomas.
Myers RB; Meredith RF; Schlom J; LoBuglio AF; Bueschen AJ; Wheeler RH; Stockard CR; Grizzle WE
J Urol; 1994 Jul; 152(1):243-6. PubMed ID: 8201675
[TBL] [Abstract][Full Text] [Related]
37. A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations.
Nuti M; Teramoto YA; Mariani-Costantini R; Hand PH; Colcher D; Schlom J
Int J Cancer; 1982 May; 29(5):539-45. PubMed ID: 6284656
[TBL] [Abstract][Full Text] [Related]
38. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of immunoreactivity of normal tissues from dogs, using monoclonal antibody B72.3.
Clemo FA; DeNicola DB; Zimmermann JL
Am J Vet Res; 1994 Aug; 55(8):1139-47. PubMed ID: 7978655
[TBL] [Abstract][Full Text] [Related]
40. Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions.
Johnston WW; Szpak CA; Lottich SC; Thor A; Schlom J
Cancer Res; 1985 Apr; 45(4):1894-900. PubMed ID: 3884146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
